Concerns are emerging over proposals to progressively replace mandatory paper medication leaflets with electronic versions accessible via QR codes and smartphones across Europe. Representatives from Germany’s pharmacy sector and the Social Association VdK have voiced reservations regarding a complete transition.
Thomas Preis, President of the German Federal Association of Pharmacists (ABDA), emphasized that while electronic leaflets can supplement printed versions, they should not be a direct substitute. He stressed the importance of ensuring all individuals have readily accessible, barrier-free information about their medications, particularly in emergency situations. Preis highlighted that many elderly or disabled individuals lack access to digital applications. He also cautioned against placing additional burdens on pharmacies and doctor’s offices, for example, by requiring them to print digital leaflets onto paper.
Verena Bentele, President of the Social Association VdK, echoed this sentiment, advocating for a dual approach: “printed and digital, so that no one is left behind”. She insisted that all patients should retain a legal right to a printed leaflet. Bentele acknowledged the advantages of digital leaflets, specifically for individuals with visual impairments who benefit from accessible digital formats.
The debate comes as part of ongoing work on a reform of European pharmaceutical law, which is expected to accelerate after the summer recess. The proposed reform aims to enhance the competitiveness of the European pharmaceutical sector and bolster the continent’s drug supply security.
While the European Commission, the European Parliament and member states agree on the increased importance of electronic patient information, some consumer and patient advocacy groups in countries like France are actively warning against the complete elimination of paper leaflets.
German Member of the European Parliament and physician Peter Liese (CDU) supports the move to digital leaflets, arguing that abolishing the paper version would facilitate the swift transfer of medication from other EU member states in the event of temporary shortages and would contribute to environmental protection by reducing paper consumption. He suggested that individuals requiring a printed copy could obtain one from their pharmacy. Liese views current technological capabilities as a significant boon for patients, particularly those with limited knowledge of the local language.